The authors of an analysis of thousands of medical records across four U.S. communities said Thursday they've found further ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

ORGANISERS of Skipton's annual Yarndale festival have announced this year's challenge for its army of global fans.

A groundbreaking daily pill could compete with weight-loss injections such as Ozempic, research suggests. In trials, people ...

The event, held April 11 on the La Jolla campus, challenged students to develop innovative solutions and, in some cases, ...

A 42-year-old woman detailed how she was given the airline-style care packages during a two-day long ordeal where she was ...

Nanoplastics can enter the brain, accumulate in organs, and trigger inflammation. Learn how these invisible pollutants impact ...

Equitage Ventures, an early-stage AgeTech venture capital firm investing in technology and technology-enabled services companies in senior care, has announced the final close of a new $47.3 million ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain ...

Today’s storylines from the UK and Australian soaps… Avoiding her mum, Avani hides out in the launderette. Yolande tries to ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...